Target intelligence / Profile preview

Ferric ion (labile pool) (LIP)

Target
LIP
Molecular classification
Metal ion, Other
01

Overview

The ferric ion (Fe3+) within the labile iron pool (LIP) refers to a fraction of cellular or systemic iron that is loosely bound to low-molecular-weight ligands like organic acids, phosphates, or polyphosphates (Kakhlon & Cabantchik, 2002). Unlike iron sequestered in storage proteins like ferritin or transport proteins like transferrin, this pool is chemically reactive and readily available for metabolic processes or pathological redox reactions (Breuer et al., 2008). In healthy cells, the LIP is maintained at low levels to provide a source of iron for the synthesis of iron-sulfur clusters and heme groups while minimizing oxidative damage. However, in conditions of iron overload, such as thalassemia or hemochromatosis, the expansion of this pool leads to the generation of hydroxyl radicals through Fenton-like chemistry, causing lipid peroxidation and cell death (Kalinowski & Richardson, 2005). Therapeutic strategies targeting this pool primarily utilize iron chelators, such as deferoxamine and deferasirox, which bind Fe3+ with high affinity to form stable complexes for excretion (Hider & Zhou, 2005). These interventions are vital for preventing organ failure in patients with chronic iron toxicity and are being explored for their potential in treating neurodegenerative diseases and cancer (Borgna-Pignatti & Marsella, 2015).

Other names
Labile iron poolLIPChelatable ironNon-transferrin-bound iron (NTBI)Labile plasma iron (LPI)Free ferric ironWeakly bound iron pool
02

Mechanism of action

Chelation of ferric ions to form stable, non-toxic complexes that are excreted from the body (Hider & Zhou, 2005).

03

Biological functions

Redox homeostasisCofactor for enzyme catalysisDNA synthesisMitochondrial respirationCell death
04

Disease associations

Iron overloadHemochromatosisThalassemiaNeurodegenerative diseaseCancerFerroptosis
05

Safety considerations

Depletion of essential iron for metabolic enzymesAgranulocytosisRenal toxicityOcular and auditory toxicityDepletion of essential trace metals
06

Interacting drugs

Deferoxamine

2 more in the full profile.

07

Biomarkers

Serum ferritinTransferrin saturationLabile plasma iron (LPI)Labile cell iron (LCI)

Beyond the preview

Go deeper on Ferric ion (labile pool) (LIP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ferric ion (labile pool) (LIP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call